Psychemedics Corporation
PMD was delisted on the 12th of December, 2024.
51 hedge funds and large institutions have $58.4M invested in Psychemedics Corporation in 2018 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 13 increasing their positions, 18 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
2% more funds holding
Funds holding: 50 → 51 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
10% less capital invested
Capital invested by funds: $64.9M → $58.4M (-$6.43M)
28% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 18
Top Buyers
Top Sellers
PMD Hedge Fund Activity: Q2 2018 in Review
51 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Psychemedics Corporation (PMD) for Q2 2018, worth a combined $58.4M — down 9.9% from $64.9M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new PMD positions and 1 closed out — a net gain of 1 holder — while 13 added to existing stakes and 18 trimmed.
The largest buyer was DePrince Race & Zollo Inc (DRZ), adding an estimated $327K. The largest seller was Uniplan Investment Counsel, cutting an estimated $510K.
- 51 institutional investors held Psychemedics Corporation (PMD) as of Q2 2018, up from 50 in Q1 2018.
- Funds reported $58.4M of Psychemedics Corporation stock for Q2 2018, down 9.9% quarter-over-quarter.
- 2 funds opened new Psychemedics Corporation positions in Q2 2018 and 1 closed out, a net change of +1 holder.
- The largest Psychemedics Corporation buyer in Q2 2018 was DePrince Race & Zollo Inc (DRZ), an estimated $327K added.
- The largest Psychemedics Corporation seller in Q2 2018 was Uniplan Investment Counsel, an estimated $510K sold.
Based on aggregated 13F filings for Q2 2018.